Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
嵌合抗原受体
免疫学
内科学
细胞因子释放综合征
医学
移植
肿瘤科
免疫疗法
免疫系统
作者
Shannon L. Maude,Noelle V. Frey,Pamela A. Shaw,Richard Aplenc,David M. Barrett,Nancy Bunin,Anne Chew,Vanessa Gonzalez,Zhaohui Zheng,Simon F. Lacey,Yolanda D. Mahnke,J. Joseph Melenhorst,Susan R. Rheingold,Angela Shen,David T. Teachey,Bruce L. Levine,Carl H. June,David L. Porter,Stephan A. Grupp
Relapsed acute lymphoblastic leukemia (ALL) is difficult to treat despite the availability of aggressive therapies. Chimeric antigen receptor–modified T cells targeting CD19 may overcome many limitations of conventional therapies and induce remission in patients with refractory disease.
mmyhn
迟大猫
热心路人
VDC
Leon
科研小民工
冬水水
pcr163
坚强的广山
杳鸢
贰鸟
zyp
成就若颜
Romy211
幽壑之潜蛟
ceeray23
万能图书馆
YJM
活力的柠檬
wuludie
皖公网安备34019202002308
